1. Home
  2. FA vs LGND Comparison

FA vs LGND Comparison

Compare FA & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Advantage Corporation

FA

First Advantage Corporation

HOLD

Current Price

$20.69

Market Cap

4.1B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$280.18

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FA
LGND
Founded
2003
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.7B
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
FA
LGND
Price
$20.69
$280.18
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$15.67
$256.29
AVG Volume (30 Days)
2.5M
204.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
72.97
2886.36
EPS
0.11
1.63
Revenue
$1,574,389,000.00
$141,102,000.00
Revenue This Year
$8.42
$1.25
Revenue Next Year
$7.26
$19.41
P/E Ratio
$190.00
$175.64
Revenue Growth
83.02
29.48
52 Week Low
$8.82
$158.13
52 Week High
$25.15
$326.63

Technical Indicators

Market Signals
Indicator
FA
LGND
Relative Strength Index (RSI) 48.63 41.47
Support Level $19.05 $181.43
Resistance Level $21.42 $322.06
Average True Range (ATR) 1.07 10.01
MACD -0.23 -1.62
Stochastic Oscillator 11.20 3.40

Price Performance

Historical Comparison
FA
LGND

About FA First Advantage Corporation

First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: